Blood chemistry lab values Flashcards
ACTH (adrenocorticotropic hormone)
AM: < 80 pg/mL (< 18 pmol./L)
PM: < 50 pg/mL (< 11 pmol/L
The serum ACTH study is a test of anterior pituitary gland function that affords the greatest insight into the causes of either Cushing syndrome (overproduction of cortisol) or Addison disease
(underproduction of cortisol).
Increased levels: Addison disease,
The reduced serum level of cortisol is a strong stimulus to pituitary production of ACTH), Stress: ACTH is overproduced as a result of neoplastic overproduction of ACTh in the pituitary or elsewhere in the body by and ACTH-producing cancer. Stress is a potent stimulus to ACTH production.
Decreased levels: Hypopituitarism: the pituitary gland is incapable of producing adequate ACTH.
Exogenous steroid administration: Overproduction or availability of cortisol is a strong inhibitor to
pituitary production of ACTH.
Anion gap
16 + 4 mEq/L (if potassium is used in the calculation)
12 +4 mEq/L (if potassium is not used in the calculation)
Calculation of the anion gap assists in the evaluation of patients with acid-base disorders. It is used to attempt to identify the potential cause of the disorder and can also be used to monitor therapy for acid-base abnormalities.
increased levels indicate: Lactic acidosis, diabetic acidosis, alcoholic ketoacidosis, alcohol intoxication, starvation (These diseases are associated with increased acid ions such as lactate, hydroxybutyrate, or acetoacetate. Bicarb neutralizes these acids, bicarb levels fall and AG mathematically increases.
Renal failure
Increased gastrointestinal losses of bicarbonate (ex. diarrhea or fistuale)
Hypoaldosteronism
Decreased levels: excess alkali ingestion( increase in alkali products (antiacids, boiled milk), especially in children, causes increased bicarb products and mathematically decrease AG. Multiple myeloma Chronic vomiting or gastric suction Hyperaldosteronism H (alypoproteinemia Lithium toxicity
ALT (alanine aminotransferase, formerly SGOT)
Elderly: may be slightly higher than adult values
Adult/child: 4-36 international units/L @ 37 C
Values may be higher in men and in African Americans
Infant: may be twice as high as adult values
This test is used to identify hepatocellular diseases of the liver. Its is also an accurate monitor of improvement or worsening of these diseases. In jaundiced patients an abnormal ALT will incriminate the liver rather than red blood cell hemolysis as a source of the jaundice. ALT is found predominately in the liver;lesser quantities are found in the kidneys, heart, and skeletal muscle. Injury or disease affecting the liver parenchyma will cause a release of this hepatocellular enzyme into the bloodstream, thus elevating serum ALT levels.
Significantly increased levels: Hepatitis, hepatic ischemia, hepatic necrosis,
moderately increased levels: cirrhosis, cholestasis, hepatic tumor, hepatotoxic drugs, obstructive jaundice, severe burns, trauma to striated muscle
mildly increased levels: myositis, pancreatitis, myocardial infarction, infectious mononucleosis, and shock.
Alkaline Phosphatase
Elderly: slightly higher than adults Adult: 30-120/L (0.5-2.0 microKat/L) Child/adolescent < 2 years: 85-235 2-8 years: 65-210 9-15 years: 60-300 16-21 years: 30-200
ALP is used to detect and monitor diseases of the liver or bone.
ALP is found in the liver and biliary epithelium. It is normally excreted into the bile. Obstruction, no matter how mild, will cause elevations in ALP.
Young children have increased ALP levels because their bones are growing. This increase is magnified during the “growth spurt,” which occurs at different ages in males and females.
Ammonia (plasma)
Adult 10-80 mcg/dL or 6-47 micromole/L
Child: 40-80 mcg/dL
Newborn: 90-150 mcg/dL
The liver normally converts ammonia, a byproduct of protein metabolism, into urea, which is excreted by the kidneys. When the liver is unable to convert ammonia to urea, toxic levels of ammonia accumulate in the bloodstream. Increased ammonia levels, which occur in liver dysfunction, may be due either to blood not circulating through the liver well or to actual hepatic failure. Ammonia is used to support the diagnosis of severe liver diseases (fulminant hepatitis or cirrhosis), and for surveillance of these diseases. Ammonia levels are also used in the diagnosis and follow-up of hepatic encephalopathy.
Amylase
60-120 units/dL 30-220 units/L
Amylase, an enzyme that helps with the digestion of starch, is found in high concentrations in the salivary glands and in the pancreas, each of which contains a different isoenzyme. These two isoenzymes can be separated to rule out nonpancreatic sources. Clients with bulimia nervosa often have enlarged salivary glands and elevated serum amylase levels. An amylase test may be used to see if induced vomiting is still occurring during treatment.
Pancreatitis is the most common reason for marked elevations in serum amylase, which begins to increase about 3 to 6 months after an attack to this disease. The severity of the the disease is not always direcetly related to the levels of the enzyme. In fact, about 10 % of patients with fatal pancreatitis have normal serum amylase levels. Renal failure may also cause abnormal elevations not related to pancreatic disease. Certain tumors, such as pheochromocytomas, myelomas, and bronchial cell carcinomas, are associated with high amylase levels.
AST (Aspartate aminotransferase formerly SGOT)
0-35 units/L (0-0.58 microKat/L)
can be used to detect liver necrosis.
AST is found predominately in heart, liver, and muscle tissue, although all tissues contain some of the enzyme. The highest amounts of them are found in high-energy cells such as the heart, liver and skeletal muscle.
Bicarbonate
23-30 mEg/L (23-30 mmol/L)
Bicarb functions as an important buffer in the bloodstream. To keep the pH in the bloodstream between 7.35-7.45. The loss of hydrogen, potassium, and chloride ions all contribute to the development of metabolic alkalosis. First, any loss of hydrogen ions causes a proportional increase in the bicarbonate side of the bicarb-carbonic acid buffering system. Secondly, when potassium is low in the serum, the kidneys are unable to excrete bicarb normally, Third, when chloride , a negative ion, is decreased in the bloodstream, another negative ion is needed to keep the positive and negative ions balanced in the serum. Thus, the kidneys cause the retention of bicarb to replace the missing chloride.
pg. 151-156 in corbett
Bilirubin
Total:
Unconjugated (Indirect, lipid soluble waste can pass through the blood brain barrier)
Conjugated (Direct, water-soluble)
0.3-1.0 mg/dL (5.1-17 micromole/L)
The total serum Bilirubin level is the sum of the conjugated (direct) and unconjugated (indirect) bilirubin.
0.2-0.8 mg/dL (3.4-12.0 micromole/L)
0.1-0.3 mg/dL (1.75-5.1 micromole/L)
An enzyme, glucuronyl transferase, is necessary for the transformation, or conjugation of bilirubin. Either a lack of glucuronyl transferase or the presence of drugs that interfere with this enzyme renders the liver unable to conjugate bilirubin. When bile reaches the intestine via the common bile duct, the bilirubin is acted on by bacteria to form chemical compounds called urobilinogens. Jaundice is recognized when the total serum bilirubin exceeds 2.5 mg/dL. Jaundice results from a defect in the normal metabolism or excretion of bilirubin. This defect can occur at any stage of heme catabolism. Once the jaundice is recognized either clinically or chemically, it is important (for therapy) to differentiate whether it is predominately caused by indirect or direct bilirubin. In general, jaundice caused by hepatocellular dysfunction (ex. hepatitis) results in elevated levels of INDIRECT bilirubin. This dysfunction usually cannot be repaired surgically. On the other hand, jaundice resulting from extrahepatic(posthepatic) dysfunction (gallstones obstructing the bile duct or a tumor doing that) results in elevated levels of DIRECT bilirubin; this type of jaundice usually can be resolved by open surgery or endoscopic surgery. Normally the indirect bilirubin makes up 70%-85% of the total bilirubin. In patients with jaundice, when more than 50% of the bilirubin is direct, it is considered a direct hyperbilirubinemia from gallstones, tumor, inflammation, scarring (cirrhosis) or obstruction of the extrahepatic ducts. Indirect hyperbilirubinemia is diagnosed when less than 15% to 20% of the total bilirubin is direct bilirubin. Diseases that typically cause this from of jaundice include accelerated erythrocyte hemolysis, hepatitis, or drugs. Physiologic jaundice of the newborn occurs if the newborn’s liver is immature and does not have enough conjugating enzymes. This results in a high circulating blood level of unconjugated bilirubin, which can pass through the blood brain barrier and deposti in the brain cells of the newborn, causing encephalopathy (kernicterus)
ANP(Atrial natriuretic Peptide)
BNP (Brain natriuretic peptide)
22-77 pg/mL (22-77 ng/L)
< 100 pg/mL (22-77 ng/L)
Natriuretic peptides are neuroendocrine peptides that oppose the activity of the renin-angiotensin system. ANP is synthesized in the cardiac atrial muscle. The main source of BNP is the cardiac ventricle. The cardiac peptides are continuously released by the heart muscles cells in low levels. BUT, the rate of release can be increased by a variety of neuroendocrine and physiologic factors, including hemodynamic load, to regulate cardiac preload and afterload. Because of these properties, BNP and ANP have been implicated in the pathophysiology of hypertension, CHF< and atherosclerosis. Both ANP and BNP are released in response to increased atrial and ventricular stretch or pressure (ex that would cause this are: CHF, MI, systemic hypertension, Heart transplant rejection, cor pulmonale {enlargement of the right ventricle of the heart as a response to increased resistance or high blood pressure in the lungs (pulmonary hypertension. aka right sided heart failure} respectively, and will cause vasorelaxation (dilation), inhibition of aldosterone secretion from the adrenal gland and renin from the kidney, thereby increasing natriuresis (excretion of sodium) and reduction in blood volume(diuresis). All of theses actions work in concert on the vessels, heart, and kidney to decrease the fluid load on the heart, allowing the heart to function better and improving cardiac performance. BNP, in particular, correlates well to left ventricular pressures. As a result, BNP is a good marker for CHF. BNP levels, by themselves, are more accurate than any historical or physical findings or laboratory values in identifying CHF as the cause of dyspnea. The higher the levels of BNP are, the more the severe the CHF. This test is used in urgent care setting to aid in the differential diagnosis of shortness of breath. If BNP is elevated, the SOB is because of CHF. If BNP levels are normal, the SOB is pulmonary and not cardiac.
Calcium
Total: 9.0-10.6 mg/dL (2.25-2.75 mmol/L)
Ionized: 4.5-5.6 mg/dL (1.05-1.30)
Critical values: < 6 or >13 mg/dL or 3.25 mmol/L
Ionized calcium: < 2.2 or > 7 mg/dL or 1.58 mmol/L
The serum calcium test is used to evaluate parathyroid function and calcium metabolism by directly measuring the total amount of calcium in the blood. Serum calcium levels are used to monitor patients with renal failure, renal transplantation, hyperparathyroidism, and various malignancies. They are also used to monitor calcium levels during and after large-volume blood transfusions.
About one half of the total calcium exists in the blood in its free (ionized) form, and about one half exits in its protein-bound form (mostly with albumin). The serum calcium level is a measure of both. As a result, when the serum albumin level is low (as in malnourished patients), the serum calcium level will also be low, and vice versa. As a rule of thumb, the total serum calcium level decreases by approximately 0.8 mg for every 1-g decrease in the serum albumin level. Serum albumin should be measure with serum calcium.
Calcitonin, a hormone secreted by the thyroid gland, protects against a calcium excess in the serum. PTH, secreted by the parathyroid gland, keeps a sufficient level of calcium in the bloodstream; an increase in PTH also decreases phosphorus levels.
Common causes of Hypercalcemia:
False rise caused by dehydration (dehydration causes the serum to be concentrated therefore rising serum levels because of fluid loss).
Hyperparathyroidism (serum phosphate level decreased)
Malignant tumors can cause elevated calcium levels in two main ways. FIrst, tumor metastasis (myeloma, lung, breast, renal cell) to the bone can destroy the bone, causing resorption and pushing calcium into the blood. Second, the cancer (lung, breast, renal cell) can produce a PTH-like substance that drives the serum calcium up (ectopic PTH).
Immobilization
Thiazide diuretics
Vitamin D intoxication (increase absorption of calcium in the GI tract and renal)
Common causes of hypocalcemia:
False decrease caused by low albumin levels
hypoparathyroidism (serum phosphate levels increased)
early neonatal hypocalcemia
chronic renal disease (serum phosphate level increased)
pancreatitis
massive blood transfusions
severe malnutrition
Carcinoembryonic antigen (CEA)
<5 ng/mL (5 mcg/L)
This tumor marker is used for determining the extent of disease and prognosis in patients with cancer (especially gastrointestinal or breast). It is also used in monitoring the disease and its treatment.
CEA is a protein that normally occurs in fetal gut tissue. By birth, detectable serum levels disappear.
It was originally thought to be a specific indicator of the presence of colorectal cancer. Subsequently, however, this tumor marker has been found in patients who have a variety of carcinomas (breast, pancreatic, gastric, hepatobiliary), sarcomas, and even many benign diseases ( ulcerative colitis, diverticulitis, cirrhosis). Chronic smokers also have elevated CEA levels.
Because the CEA level can be elevated in both benign and malignant diseases, it is not a specific test for colorectal cancer. Furthermore, not all colorectal cancers produce CEA. Therefore CDEA is not a reliable screening test for the detection of colorectal cancer in the general population.
This test is also used in the surveillance of patients with cancer. A steadily rising CEA level is occasionally the first sign of tumor recurrence. This makes CEA testing very valuable in the follow-up of patients who have already had potentially curative therapy. CEA can also be detected in body fluids other than blood. Its presence in those body fluids indicates metastasis. This test is commonly performed on peritoneal fluid or chest effusions. Elevated CEA levels in these fluids indicate metastasis to the peritoneum or pleura, respectively. Likewise, elevated CEA levels in the cerebrospinal fluid indicate central nervous system metastasis.
Chloride
98-106 mEq/L (98-106 mmol/L)
Critical value: 115 mEq/L
By itself, this test does not provide much information. However, with interpretation of the other electrolytes, chloride can give an indication of acid-base balance and hydration status. Its primary purpose is to maintain electrical neutrality, mostly as a salt with sodium. It follows sodium (cation) losses and accompanies sodium excesses in an attempt to maintain electrical neutrality. for example, when aldosterone encourage sodium reabsorption, chloride follows to maintain electrical neutrality.
Hypochloremia and hyperchloremia rarely occur alone and usually are part of parallel shifts in sodium or bicarb levels. Signs and symptoms of hypochloremia include hyperexcitability of the nervous system and muscles, shallow breathing, hypotension, and tetany. Signs and symptoms of hyperchloremia include lethargy weakness, and deep breathing.
Cholesterol
Adult/elderly or = to 240 mg/dL
Cholesterol is the main lipid associated with atertiosclerotic vascular disease. Cholesterol, however, is require for the production of steroids, sex hormones, bile acids, and cellular membranes. Most of the cholesterol we eat comes from foods of animal origin. The liver metabolizes the cholesterol to its free form, and cholesterol is transported in the bloodstream by lipoproteins. Nearly 75% of the cholesterol is bound to low-density lipoproteins(LDL), and 25% is bound to high-density lipoproteins(HDL). Cholesterol is the main component of LDL and only a minimal component of HDL and very-low-density lipoprotein (VLDL). It is the LDL that is most directly associated with increased risk for CHD.
Cortisol
Time -0800: 5-23 mcg/dL (138-635 nmol/L)
1400: 3-13 mcg/dL (83-359 nmol/L)
This test is performed on patients who are suspected to have hyperfunctioning or hypofunctioning adrenal glands.
Increased serum cortisol level: An increase in cortisol can be either ACTH-dependent or ACTH-independent. A pituitary tumor can cause an increase of ACTH, which causes and increased cortisol level. This type of cortisol increase is ACTH-dependent, and it is sometimes called Cushing’s DISEASE. Increases of serum cortisol from other causes are called Cushing’s SYNDROME.
Plasma cortisol levels increase independently of the pituitary gland when there is hyperplasia of the adrenal cortex. Hypersecreting tumors of the adrenal cortex may be malignant or benign.
Some nonendocrine malignant tumors can secrete ACTH, which can result in increased serum cortisol levels. Cushing’s syndrome can be caused by the administration of corticosteroids over a long period of time.